These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8646471)

  • 1. An evaluation of the copper-bromide laser for treating telangiectasia.
    McCoy S; Hanna M; Anderson P; McLennan G; Repacholi M
    Dermatol Surg; 1996 Jun; 22(6):551-7. PubMed ID: 8646471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A laser therapy concept in telangiectasis and naevus flammeus].
    Schwager K; Waner M; Höhmann D
    Laryngorhinootologie; 1994 May; 73(5):287-90. PubMed ID: 8018246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper bromide laser treatment of facial telangiectasia: results of patients treated over five years.
    McCoy SE
    Lasers Surg Med; 1997; 21(4):329-40. PubMed ID: 9328980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulsed color laser for treatment of benign, superficial vascular malformations].
    Gosepath K; Mann W
    Laryngorhinootologie; 1995 Aug; 74(8):500-3. PubMed ID: 7575902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of the frequency-doubled Q-switched Nd:YAG laser in the treatment of small cutaneous vascular lesions.
    Goldberg DJ; Marcus J
    Dermatol Surg; 1996 Oct; 22(10):841-4. PubMed ID: 9246165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utilization of a new yellow light laser (578 nm) for the treatment of class I red telangiectasia of the lower extremities.
    Sadick NS; Weiss R
    Dermatol Surg; 2002 Jan; 28(1):21-5. PubMed ID: 11991264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective destruction of facial telangiectasia using a copper vapor laser.
    Key JM; Waner M
    Arch Otolaryngol Head Neck Surg; 1992 May; 118(5):509-13. PubMed ID: 1571124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects associated with the 577- and 585-nanometer pulsed dye laser in the treatment of cutaneous vascular lesions: a study of 500 patients.
    Levine VJ; Geronemus RG
    J Am Acad Dermatol; 1995 Apr; 32(4):613-7. PubMed ID: 7896952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of facial telangiectasia using a dual-wavelength laser system (595 and 1,064 nm): a randomized controlled trial with blinded response evaluation.
    Karsai S; Roos S; Raulin C
    Dermatol Surg; 2008 May; 34(5):702-8. PubMed ID: 18318728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of a single-session pro-yellow laser in the treatment of facial telangiectasia.
    Turkmen D; Altunisik N; Sener S
    Lasers Med Sci; 2021 Mar; 36(2):401-406. PubMed ID: 32592131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser use for cutaneous vascular alterations of cosmetic interest.
    Bencini PL; Tourlaki A; De Giorgi V; Galimberti M
    Dermatol Ther; 2012; 25(4):340-51. PubMed ID: 22950561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of facial telangiectases with the diode-pumped frequency-doubled Q-switched Nd:YAG laser.
    Goldberg DJ; Meine JG
    Dermatol Surg; 1998 Aug; 24(8):828-32. PubMed ID: 9723046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of copper vapor and flashlamp pumped dye lasers in the treatment of facial telangiectasia.
    Waner M; Dinehart SM; Wilson MB; Flock ST
    J Dermatol Surg Oncol; 1993 Nov; 19(11):992-8. PubMed ID: 8245305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of telangiectases and other benign vascular lesions with the 577 nm pulsed dye laser.
    Gonzalez E; Gange RW; Momtaz KT
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):220-6. PubMed ID: 1430360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the long-pulse dye laser for the treatment of leg telangiectasias.
    Reichert D
    Dermatol Surg; 1998 Jul; 24(7):737-40. PubMed ID: 9693667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient's questionnaire evaluation of krypton laser treatment of facial telangiectases. A comparison with the copper vapor laser.
    Thibault PK
    Dermatol Surg; 1997 Jan; 23(1):37-41. PubMed ID: 9107292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intense light source. The photoderm VL-flashlamp as a new treatment possibility for vascular skin lesions.
    Schroeter CA; Neumann HA
    Dermatol Surg; 1998 Jul; 24(7):743-8. PubMed ID: 9693668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laser.
    Clark C; Cameron H; Moseley H; Ferguson J; Ibbotson SH
    Lasers Med Sci; 2004; 19(1):1-5. PubMed ID: 15316851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal management of facial telangiectasia.
    Goldman MP
    Am J Clin Dermatol; 2004; 5(6):423-34. PubMed ID: 15663339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of angioma serpiginosum using a pulsed tunable dye laser.
    Long CC; Lanigan SW
    Br J Dermatol; 1997 Apr; 136(4):631-2. PubMed ID: 9155976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.